HyperACP: A cutting-edge hybrid framework for anticancer peptide classification via scalable feature extraction and adaptive neighbor-based synthesis
PLOS Computational Biology · 11.09.2025 · 21 (9) · e1013489
DOI: 10.1371/journal.pcbi.1013489 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, online erschienen am 11.09.2025. Verfasst von Bangyi Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Artificial Intelligence and Computer Science, Jiangnan University, Wuxi, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Peptides, Computational Biology. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Basic Research Program of Jiangsu, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Cancer remains a major contributor to global mortality, constituting a significant and escalating threat to human health. Anticancer peptides (ACPs) have emerged as promising therapeutic agents due to their specific mechanisms of action, pronounced tumor-targeting capability, and low toxicity. Nevertheless, traditional approaches for ACP identification are constrained by their reliance on shallow, hand-crafted sequence features, which fail to capture deeper semantic and structural characteristics. Moreover, such models exhibit limited robustness and interpretability when confronted with practical challenges such as severe class imbalance. To address these limitations, this study proposes HyperACP, an innovative framework for ACP recognition that integrates deep representation learning, adaptive sampling, and mechanistic interpretability. The framework leverages the ESMC protein language model to extract comprehensive sequence features and employs a novel adaptive algorithm, ANBS, to mitigate class imbalance at the decision boundary. For enhanced model transparency, SHAP-Res is incorporated to elucidate the contributions of individual residues to the final predictions. Comprehensive evaluations demonstrate that HyperACP consistently outperforms state-of-the-art methods across multiple datasets and validation protocols—including 10-fold cross-validation and independent test sets—according to metrics such as Accuracy (ACC), Sensitivity (SN), Specificity (SP), Matthews Correlation Coefficient (MCC), and Area Under the Curve (AUC). Furthermore, the model yields biologically interpretable results, pinpointing key residues (K, L, F, G) known to play pivotal roles in anticancer activity. These findings provide not only a robust predictive tool (available at www.hyperacp.com ) but also novel insights into the structure-function relationships underlying ACPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Artificial Intelligence and Computer Science, Jiangnan University, Wuxi, China.
- Department of Computer Science and Technology, National Institute for Data Science in Health and Medicine, Xiamen Key Laboratory of Intelligent Storage and Computing, Xiamen University, Xiamen, China.
- School of Information Science and Engineering, Hunan University, Yuelu, Changsha, China.
ORCID-Profile: Yun Zuo
Förderung
- National Natural Science Foundation of China
- Basic Research Program of Jiangsu
- Fundamental Research Funds for the Central Universities
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
- the Funded by Basic Research Program of Jiangsu
Zitieren
APA
Zhang, B., Zuo, Y., Wan, J., Liu, J., Liu, X., Zeng, X., & Deng, Z. (2025). HyperACP: A cutting-edge hybrid framework for anticancer peptide classification via scalable feature extraction and adaptive neighbor-based synthesis. PLOS Computational Biology, 21(9), e1013489. https://doi.org/10.1371/journal.pcbi.1013489
Vancouver
Zhang B, Zuo Y, Wan J, Liu J, Liu X, Zeng X, et al. HyperACP: A cutting-edge hybrid framework for anticancer peptide classification via scalable feature extraction and adaptive neighbor-based synthesis. PLOS Computational Biology. 2025;21(9):e1013489. doi:10.1371/journal.pcbi.1013489
BibTeX
@article{Zhang2025,
author = {Zhang, Bangyi and Zuo, Yun and Wan, Jun and Liu, Jiayue and Liu, Xiangrong and Zeng, Xiangxiang and Deng, Zhaohong},
title = {HyperACP: A cutting-edge hybrid framework for anticancer peptide classification via scalable feature extraction and adaptive neighbor-based synthesis},
journal = {PLOS Computational Biology},
year = {2025},
volume = {21},
number = {9},
pages = {e1013489},
doi = {10.1371/journal.pcbi.1013489}
}
EUVIMED